<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="[MASC]/data/written/wsj_0032.anc" start="475" end="483" sStart="456" offset="19" sid="null" wn="1" wnkey="launch%2:41:01::" text="The offer is being launched pursuant to a previously announced agreement between the companies." />
    <s path="[MASC]/data/written/wsj_0032.anc" start="426" end="432" sStart="null" offset="50" sid="null" wn="1" wnkey="common%3:00:02::" text="Montedison currently owns about 72% of Erbamont's common shares outstanding." />
    <s path="[MASC]/data/written/wsj_0032.anc" start="149" end="155" sStart="null" offset="145" sid="null" wn="1" wnkey="common%3:00:02::" text="Italian chemical giant Montedison S.p. A., through its Montedison Acquisition N.V. indirect unit, began its $37-a-share tender offer for all the common shares outstanding of Erbamont N.V., a maker of pharmaceuticals incorporated in the Netherlands" />
    <s path="[MASC]/data/written/wsj_0032.anc" start="426" end="432" sStart="null" offset="50" sid="r10.common.j.0054" wn="2147483647" wnkey="null" text="Montedison currently owns about 72% of Erbamont's common shares outstanding." />
    <s path="[MASC]/data/written/wsj_0032.anc" start="149" end="155" sStart="null" offset="145" sid="r10.common.j.0053" wn="2147483647" wnkey="null" text="Italian chemical giant Montedison S.p. A., through its Montedison Acquisition N.V. indirect unit, began its $37-a-share tender offer for all the common shares outstanding of Erbamont N.V., a maker of pharmaceuticals incorporated in the Netherlands" />
    <s path="[MASC]/data/written/wsj_0032.anc" start="426" end="432" sStart="null" offset="50" sid="null" wn="1" wnkey="common%3:00:02::" text="Montedison currently owns about 72% of Erbamont's common shares outstanding." />
    <s path="[MASC]/data/written/wsj_0032.anc" start="149" end="155" sStart="null" offset="145" sid="null" wn="1" wnkey="common%3:00:02::" text="Italian chemical giant Montedison S.p. A., through its Montedison Acquisition N.V. indirect unit, began its $37-a-share tender offer for all the common shares outstanding of Erbamont N.V., a maker of pharmaceuticals incorporated in the Netherlands" />
    <s path="[MASC]/data/written/wsj_0032.anc" start="426" end="432" sStart="null" offset="50" sid="r10.common.j.0054" wn="1" wnkey="common%3:00:02::" text="Montedison currently owns about 72% of Erbamont's common shares outstanding." />
    <s path="[MASC]/data/written/wsj_0032.anc" start="149" end="155" sStart="null" offset="145" sid="r10.common.j.0053" wn="1" wnkey="common%3:00:02::" text="Italian chemical giant Montedison S.p. A., through its Montedison Acquisition N.V. indirect unit, began its $37-a-share tender offer for all the common shares outstanding of Erbamont N.V., a maker of pharmaceuticals incorporated in the Netherlands" />
    <s path="[MASC]/data/written/wsj_0032.anc" start="426" end="432" sStart="null" offset="50" sid="null" wn="1" wnkey="common%3:00:02::" text="Montedison currently owns about 72% of Erbamont's common shares outstanding." />
    <s path="[MASC]/data/written/wsj_0032.anc" start="149" end="155" sStart="null" offset="145" sid="null" wn="1" wnkey="common%3:00:02::" text="Italian chemical giant Montedison S.p. A., through its Montedison Acquisition N.V. indirect unit, began its $37-a-share tender offer for all the common shares outstanding of Erbamont N.V., a maker of pharmaceuticals incorporated in the Netherlands" />
    <s path="[MASC]/data/written/wsj_0032.anc" start="426" end="432" sStart="null" offset="50" sid="r10.common.j.0054" wn="2147483647" wnkey="null" text="Montedison currently owns about 72% of Erbamont's common shares outstanding." />
    <s path="[MASC]/data/written/wsj_0032.anc" start="149" end="155" sStart="null" offset="145" sid="r10.common.j.0053" wn="2147483647" wnkey="null" text="Italian chemical giant Montedison S.p. A., through its Montedison Acquisition N.V. indirect unit, began its $37-a-share tender offer for all the common shares outstanding of Erbamont N.V., a maker of pharmaceuticals incorporated in the Netherlands" />
    <s path="[MASC]/data/written/wsj_0032.anc" start="426" end="432" sStart="null" offset="50" sid="null" wn="2" wnkey="common%3:00:01::" text="Montedison currently owns about 72% of Erbamont's common shares outstanding." />
    <s path="[MASC]/data/written/wsj_0032.anc" start="149" end="155" sStart="null" offset="145" sid="null" wn="2" wnkey="common%3:00:01::" text="Italian chemical giant Montedison S.p. A., through its Montedison Acquisition N.V. indirect unit, began its $37-a-share tender offer for all the common shares outstanding of Erbamont N.V., a maker of pharmaceuticals incorporated in the Netherlands" />
    <s path="[MASC]/data/written/wsj_0032.anc" start="426" end="432" sStart="null" offset="50" sid="r10.common.j.0054" wn="1" wnkey="common%3:00:02::" text="Montedison currently owns about 72% of Erbamont's common shares outstanding." />
    <s path="[MASC]/data/written/wsj_0032.anc" start="149" end="155" sStart="null" offset="145" sid="r10.common.j.0053" wn="1" wnkey="common%3:00:02::" text="Italian chemical giant Montedison S.p. A., through its Montedison Acquisition N.V. indirect unit, began its $37-a-share tender offer for all the common shares outstanding of Erbamont N.V., a maker of pharmaceuticals incorporated in the Netherlands" />
  </sentences>
</list>